Paclitaxel as the initial treatment of multiple myeloma: an Eastern Cooperative Oncology Group Study (E1A93).

Miller, H J; Leong, T; Khandekar, J D; Greipp, P R; Gertz, M A; Kyle, R A

Miller, H J; Leong, T; Khandekar, J D; Greipp, P R; Gertz, M A; Kyle, R A.

Affiliation

Miller HJ; Evanston Hospital, Illinois, USA.

Am J Clin Oncol ; 21(6): 553-6, 1998 Dec.

Article in En | MEDLINE | ID: mdl-9856654

Subject(s)

Antineoplastic Agents, Phytogenic/therapeutic use; Multiple Myeloma/drug therapy; Paclitaxel/therapeutic use; Adult; Aged; Antineoplastic Agents, Phytogenic/administration & dosage; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor/therapeutic use; Humans; Male; Middle Aged; Paclitaxel/administration & dosage; Survival Analysis

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Paclitaxel / Multiple Myeloma / Antineoplastic Agents, Phytogenic Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Clin Oncol Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links